Table 1 Demographics and clinical characteristics of the two study groups
Demographic/clinical characteristics | Training group | p value | Testing group | p value | ||
|---|---|---|---|---|---|---|
| Â | EGF | DGF | EGF | DGF | ||
Patients (n) | 7 | 7 | Â | 5 | 5 | Â |
Gender (M/F) | 4/3 | 3/4 | n.s. | 2/3 | 3/2 | n.s. |
Recipient age (years) | 47.1 ± 9.3 | 48.3 ± 8.4 | n.s. | 46.3 ± 10.1 | 47.7 ± 7.5 | n.s. |
Donor age (years) | 47.3 ± 9.3 | 51.9 ± 12.6 | n.s. | 49.1 ± 6.4 | 49.5 ± 5.9 | n.s. |
Donor cause of death (trauma/others) | 3/4 | 3/4 | n.s. | 2/3 | 2/3 | n.s. |
HLA mismatches (n) | 3.4 ± 1.2 | 3.5 ± 0.8 | n.s. | 3.4 ± 1.1 | 3.5 ± 0.9 | n.s. |
Cold ischemia time (h) | 12.1 ± 3.8 | 17.4 ± 5.1 | <0.05 | 11.2 ± 2.3 | 16.8 ± 4.3 | 0.01 |
Length of DGF (days) | 0 | 17.8 ± 12.8 | <0.001 | 0 | 14.2 ± 16.3 | <0.001 |